<code id='4068805A08'></code><style id='4068805A08'></style>
    • <acronym id='4068805A08'></acronym>
      <center id='4068805A08'><center id='4068805A08'><tfoot id='4068805A08'></tfoot></center><abbr id='4068805A08'><dir id='4068805A08'><tfoot id='4068805A08'></tfoot><noframes id='4068805A08'>

    • <optgroup id='4068805A08'><strike id='4068805A08'><sup id='4068805A08'></sup></strike><code id='4068805A08'></code></optgroup>
        1. <b id='4068805A08'><label id='4068805A08'><select id='4068805A08'><dt id='4068805A08'><span id='4068805A08'></span></dt></select></label></b><u id='4068805A08'></u>
          <i id='4068805A08'><strike id='4068805A08'><tt id='4068805A08'><pre id='4068805A08'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:entertainment    Page View:5
          Photo illustration of a checkbook wrapped with lock and chain – hospital and investment coverage from STAT
          Alex Hogan/STAT

          Hospitals once dove headfirst into venture capital with splashy headlines and attention-grabbing numbers. Now, in an era of flattened margins and exceedingly uncertain returns, many health systems are quietly pulling back.

          NewYork-Presbyterian’s venture firm, once managing roughly $40 million in assets, was essentially dissolved, two former employees said, with leaders punting it from the system’s strategy division to innovation, then from innovation to the investment office — a spokesperson described it as being “integrated” into the broader strategy. PitchBook data show no investments after 2020.

          advertisement

          Advocate Health Enterprises, meanwhile, the venture firm of a 67-hospital system based in Charlotte, N.C., has lost at least six employees within the past year, including its president, from a staff that once included about a dozen people.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays
          Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

          DarronCummings/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechne

          read more
          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more

          CDC says it’s too soon to assess risk posed by Covid subvariant

          Anursepreparesadoseofthispastspring'sCovid-19boostershot.JacobKing/WPAPoolviaGettyImagesTheCentersfo